In May 2023, the Governor’s Office of Drug Policy convened a group of stakeholders from various areas of expertise who were dedicated and committed to reducing the burden of the opioid crisis in Idaho. The workgroup gathered for a two-day retreat, followed by additional meetings and phone calls, to create a statewide, collaborative opioid misuse and overdose prevention blueprint; leading to the development of the “2023-2028 Idaho Opioid Misuse and Overdose Prevention Strategic Plan.” The five-year Strategic Plan identified three key goal areas that addressed the epidemic with a comprehensive, multi-sector approach to support the workgroup’s 2023 vision of “an Idaho that cares for those impacted by opioids.”
The Idaho Opioid Misuse & Overdose workgroup held its first retreat for the new iteration of the five-year plan in May 2023. Read the full 2023 Update | Idaho Opioid Misuse and Overdose Prevention Strategic Plan 2023 – 2028.
- Center for Hope
- Latah Recovery Center
- Marimn Health
- Cedar House Mental Wellness & Recovery Services
- Nimiipuu Health Clinic
- Terry Reilly Health Services
- Recovery Idaho
- Boise State University
- Drug Overdose Prevention Program, Idaho Department of Health and Welfare
- Idaho National Guard
- Ada County Prosecutor’s Office
- Ada County Paramedics
- Eastern Idaho Public Health
- Panhandle Health District
- Southwest District Health
- Central District Health
- South Central Public Health
- Southeastern Idaho Public Health
- Northwest Portland Area Indian Health Board
- Idaho State Pharmacy Association
- Idaho Retailers Association
- Idaho Office of Drug Policy
- 2022 Update – Idaho Opioid Misuse and Overdose Strategic Plan
- 2021 Update – Idaho Opioid Misuse and Overdose Strategic Plan
- 2020 Update – Idaho Opioid Misuse and Overdose Strategic Plan
- 2019 Substance Misuse Prevention Needs Assessment
- Prescription Opioids Fact Sheet 2021
- Idaho Department of Health and Welfare Vital Statistics
- Idaho’s Response to the Opioid Crisis (IROC)
- StopOverdoseIdaho.org
- ODP Drug Information: Opioids and Overdoses
If you are interested in participating in the workgroup or would like further information, please contact Marianne King at 208-854-3040.